Signal Genetics Taps NeoGenomics to Market Array-Based Myeloma Test to US Hospitals

Startup Signal Genetics has decided to partner with specialty labs that have existing relationships with its target market instead of creating its own sales organization.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.